The effect of self-management training program on self-efficacy of disease management and quality of life of patients with scleroderma
Not Applicable
Recruiting
- Conditions
- Scleroderma.Diseases of the musculoskeletal system and connective tissueM00-M99
- Registration Number
- IRCT20230715058789N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Diagnosis of scleroderma disease based on classification indices of the American University of Rheumatology and its evaluation and confirmation by a rheumatologist
Age equal to or greater than 18 years
Ability to communicate in Farsi
Non-diagnosis of mental disorders based on the statement of the patient and family
No use of psychoactive drugs in the last three months
Ability to answer questions
Failure to participate in any self-management or rehabilitation program within the past three months
More than one year has passed since the disease
Exclusion Criteria
Scleroderma patients hospitalized in wards
Simultaneously suffering from other musculoskeletal diseases such as lupus, rheumatoid arthritis, Behcet's syndrome, etc.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The self-efficacy of disease management score in the Self-Efficacy for Managing Chronic Disease questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Self-Efficacy for Managing Chronic Disease Questionnaire.;The quality of life score in the Systemic Sclerosis Quality of Life Questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention and three months after the end of the intervention. Method of measurement: Systemic Sclerosis Quality of Life Questionnaire.
- Secondary Outcome Measures
Name Time Method